Wiedendiol B

Drug Profile

Wiedendiol B

Alternative Names: SCH 50680

Latest Information Update: 12 Jul 1999

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nonindustrial source; Schering-Plough
  • Class Antihyperlipidaemics; Sesquiterpenes
  • Mechanism of Action Cholesterol ester transfer protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Atherosclerosis; Hyperlipidaemia

Most Recent Events

  • 12 Jul 1999 No-Development-Reported for Atherosclerosis in USA (Unknown route)
  • 12 Jul 1999 No-Development-Reported for Hyperlipidaemia in USA (Unknown route)
  • 16 Jul 1996 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top